| 4.6 -0.2 (-4.35%) | 10-09 15:42 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 5.87  |
1-year : | 6.42 |
| Resists | First : | 5.02 |
Second : | 5.5 |
| Pivot price | 4.82 |
|||
| Supports | First : | 4.26 |
Second : | 3.54 |
| MAs | MA(5) : | 4.68 |
MA(20) : | 4.85 |
| MA(100) : | 4.93 |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 29.4 |
D(3) : | 34.6 |
| RSI | RSI(14): 37.3 |
|||
| 52-week | High : | 7.76 | Low : | 3.38 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ CJMB ] has closed below the lower bollinger band by 19.3%. Although price has broken the lower band and a downside breakout is possible; the most likely direction for [ CJMB ] is to continue within current trading range. Bollinger Bands are 35.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.89 - 4.92 | 4.92 - 4.93 |
| Low: | 4.36 - 4.39 | 4.39 - 4.41 |
| Close: | 4.56 - 4.6 | 4.6 - 4.64 |
Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides perishable (non-pharma) client packaging, and technical services. The company was founded in 2006 and is headquartered in Spring Branch, Texas.
Tue, 02 Sep 2025
Callan JMB to Participate in Upcoming September Conferences - GlobeNewswire
Thu, 14 Aug 2025
Callan JMB Announces Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Thu, 17 Jul 2025
Callan JMB Extends Long-Term Contract with City of Chicago and Receives Increase in Funding - GlobeNewswire
Thu, 17 Jul 2025
Companies Like Callan JMB (NASDAQ:CJMB) Are In A Position To Invest In Growth - simplywall.st
Wed, 21 May 2025
Callan JMB and Revival Health Form Joint Venture to - GlobeNewswire
Wed, 21 May 2025
Callan JMB and Revival Health launch joint venture for healthcare logistics - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Industrials
|
|
|
Industry:
Integrated Freight & Logistics
|
|
| Shares Out | 4 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 70.8 (%) |
| Held by Institutions | 15.8 (%) |
| Shares Short | 24 (K) |
| Shares Short P.Month | 5 (K) |
| EPS | -1.06 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.29 |
| Profit Margin | -80.4 % |
| Operating Margin | -84.2 % |
| Return on Assets (ttm) | -36.7 % |
| Return on Equity (ttm) | -85.9 % |
| Qtrly Rev. Growth | -16.2 % |
| Gross Profit (p.s.) | 0.47 |
| Sales Per Share | 1.31 |
| EBITDA (p.s.) | -1.02 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -2 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | -4.17 |
| PEG Ratio | 0 |
| Price to Book value | 3.39 |
| Price to Sales | 3.35 |
| Price to Cash Flow | -10.64 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|